EUVIMEDEUVIMED entdecken
FallberichtLeserbrief

Novel compound heterozygous mutations of the COL7A1 gene in a Chinese patient with recessive dystrophic epidermolysis bullosa pruriginosa and digestive symptoms successfully treated with tofacitinib

Xingli Zhou iD, Jia Geng, Minjin Wang, Jinlin Yang, Jian Zou, Wei Li iD

The Journal of Dermatology · 2024

DOI: 10.1111/1346-8138.16945 ↗

Kurz gefasst

Fallbericht in der Zeitschrift The Journal of Dermatology, 2024. Verfasst von Xingli Zhou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology & Venerology, Rare Diseases Center, West China Hospital, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Epidermolysis Bullosa Dystrophica. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 5 Literaturangaben. Gefördert von: 1·3·5 project for disciplines of excellence, West China Hospital, Sichuan University, postdoctoral fund of Sichuan University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epidermolysis Bullosa DystrophicaHumansChinaCollagen Type VIIGenes, RecessiveMutationPedigreePhenotypePiperidinesPyrimidines

Substanzen

Collagen Type VIICOL7A1 protein, humantofacitinibPiperidinesPyrimidines

Autor:innen und Institutionen

  • Department of Dermatology & Venerology, Rare Diseases Center, West China Hospital, Sichuan University, Chengdu, China.
  • Institute of Rare Diseases, West China Hospital, Sichuan University, Chengdu, China.
  • Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, China.
  • Department of Neurology, West China Hospital, Sichuan University, Chengdu, China.
  • Department of Gastroenterology and Hepatology, West China Hospital, Sichuan University, Chengdu, China.
  • Department of Otolaryngology-Head & Neck Surgery, West China Hospital, Sichuan University, Chengdu, China.

ORCID-Profile: Xingli Zhou, Wei Li

Förderung

  • 1·3·5 project for disciplines of excellence, West China Hospital, Sichuan University
  • postdoctoral fund of Sichuan University

Zitieren

APA

Zhou, X., Geng, J., Wang, M., Yang, J., Zou, J., & Li, W. (2024). Novel compound heterozygous mutations of the COL7A1 gene in a Chinese patient with recessive dystrophic epidermolysis bullosa pruriginosa and digestive symptoms successfully treated with tofacitinib. The Journal of Dermatology. https://doi.org/10.1111/1346-8138.16945

Vancouver

Zhou X, Geng J, Wang M, Yang J, Zou J, Li W. Novel compound heterozygous mutations of the COL7A1 gene in a Chinese patient with recessive dystrophic epidermolysis bullosa pruriginosa and digestive symptoms successfully treated with tofacitinib. The Journal of Dermatology. 2024. doi:10.1111/1346-8138.16945

BibTeX
@article{Zhou2024,
  author = {Zhou, Xingli and Geng, Jia and Wang, Minjin and Yang, Jinlin and Zou, Jian and Li, Wei},
  title = {Novel compound heterozygous mutations of the COL7A1 gene in a Chinese patient with recessive dystrophic epidermolysis bullosa pruriginosa and digestive symptoms successfully treated with tofacitinib},
  journal = {The Journal of Dermatology},
  year = {2024},
  doi = {10.1111/1346-8138.16945}
}
Kostenlos starten →